Three Penn Medicine’s https://www.pennmedicine.org, projects developed at their Center for Health Care Innovation were chosen by Independence Blue Cross to receive Clinical Care Innovation Grants. Each grant averages $200,000 per grant to develop projects through trials to expand their use.
The project titled LiveAware is a digital platform designed to increase screening rates for patients at risk for Hepatocellular Carcinoma (HCC). The digital platform eliminates the burden on physicians to know who is eligible for screening and streamlines ordering
In order to deal with this cancer at a treatable stage, patients should be screened for HCC every six months with an abdominal ultrasound. However, as many as 60 percent of patients are diagnosed too late to be cured.
The second project called Penn AI a completely free AI data analysis tool, is an automated machine learning system was recently launched. Penn AI uses an artificial intelligence engine to work out analyses of datasets with minimal human input using different variables and methods.
The research team is also working with Penn Medicine Information Services to integrate Penn AI with PennTURBO, which works to make better connections between relevant clinical data and research.
The third grant project is developing remote supervised cardiac rehabilitation for patients recovering from acute events related to heart disease by engaging patients at home in an exercise-based, multidisciplinary program. The goal is to reduce hospital readmissions, recurrent cardiac events, and mortality.